• 청정기술
• /
• 제26권1호
• /
• pp.1-6
• /
• 2020

초임계 용액 급속팽창법(rapid expansion of supercritical solution, RESS)으로 몰시도민(molsidomine, MOL) 약물이 로딩 된 퍼아세틸-β-사이클로덱스트린(PAc-β-CD) 나노 입자를 제조하였다. 입자는 초임계 용액을 공기 중으로 급속하게 팽창시켜 제조하였다. MOL과 PAc-β-CD (0.5, 1 wt%)의 농도, 추출 온도(45 ~ 60 ℃), 모세관 노즐의 길이(5 ~ 20 mm) 및 내경(Inner diameter, ID) (50 ~ 150 μm), 그리고 분사 거리의 변화에 따라 형성된 입자의 크기와 모폴로지를 조사하였다. MOL과 PAc-β-CD의 상호작용을 ¹H-NMR 분광법으로 확인하였고, 입자 크기는 주사 전자 현미경으로 측정하였다. 온도를 45 ℃에서 60 ℃로 올리거나 노즐 내경을 150 μm에서 50 μm로 줄이면 입자 평균 크기가 증가하였으며, 반면에 일정한 압력(34.5 MPa)과 온도(45 ℃)에서 분사 거리를 늘리면 입자 평균 크기가 감소하는 효과를 나타내었다. 0.5 wt%의 PAc-β-CD 농도로서 초임계 공정을 진행한 결과, 모세관의 길이가 짧고(5 mm) 내경이 작은(50 μm) 조건에서 크기가 가장 작은(165 nm) 입자가 얻어졌다. 제조한 나노 입자는 오일 내에서 분산성과 용해도가 증가하였으며, 포접체 입자에서 MOL이 방출되는 시간이 지연되는 것을 확인하였다.

• 한국가축번식학회지
• /
• 제24권1호
• /
• pp.89-95
• /
• 2000

본 실험은 초자화동결된 소 배반포기배를 실험현장에서 효율적으로 융해할 수 있는 기술을 찾고자 실시하였다. 초자화동결은 glycerol (G)과 ethylene glycol (EG) 그리고 10% FBS가 들어있는 m-DPBS를 이용하였으며, 배반포기배는 3단계로 초자화동결 되었는데, 10% G에 5분간 평형, 10% G와 20% EG에 5분간 평형, 그리고 25% G와 25% EG에 30초간 노출하였다. 질소 증기를 3분간 씌고 액화질소에 침지하였다. 융해는 straw 를 공기 중에서 10초간 노출시키고, $25^{\circ}C$ 물에서 빙정이 없어질 때까지 녹인 후 $25^{\circ}C$ 와 36$^{\circ}C$ 에 각각 시간차에 따라 처리군을 나누었다. 초자화동결된 배반포기배를 융해시 시간차에 따라 체외생존능은 융해 24시간과 48시간 후 재팽창과 완전탈출 배반포기배로 평가하였다. 그 결과를 요약하면 다음과 같다. 1) 초자화 동결된 배반포기를 융해시 시간차에 따라 체외생존농을 보았을 때, 1분으로 융해한 군이(86.6, 56.6%) 다른 처리군들보다 (2분 : 93.5, 35.4% ; 2.5분 : 76.9, 30.7% ; 3분 : 88.8, 36.1%; 3.5분 : 83.7, 8.1%) 체외생존능이 높게 나타났다. 2) 1분 융해방법으로 배반포기배의 발달단계에 따라 생존능을 조사하였을 때, 융해 48시간 후 빠르게 발달된 배반포기배의 부화율 (팽윤 : 93.8, 56.3% : 부화초기 : 86.2, 58.6%)은 느리게 발달하는 난자군의 부화율 (초기 : 83.3, 36.6%) 보다 높은 체외생존능을 나타내었다. 3) 또한, 1분 융해방법으로 배반포기배가 생산된 나이에 따라 체외생존능을 조사하였을 때, 융해 48시간 후, 7일 (66.6%) 과 8일 (60.0%)에 생산된 배반포기배가 9일 (22.7%)에 생산된 완전탈출 배반포기배율 보다 유의하게 높은 체외생존율을 나타내었다 (P＜0.05). 그러므로 초자화동결된 배반포기배를 1분 융해방법으로 융해하였을 때 빠르고 효율적으로 체외생존능을 얻을 수 있음을 알 수 있었다.

• 대한임상검사과학회지
• /
• 제36권2호
• /
• pp.163-172
• /
• 2004

Mast cells (MCs) have been implicated in the pathogenesis of tissue fibrosis. However, the role of MC in the development of liver fibrosis has not been fully elucidated. Stem cell factor (SCF) is known to recruit MCs to the liver following injury as it induces mast cell proliferation, survival and differentiation from resident tissue precursors. This study examines the interaction between activated hepatic stellate cells (HSCs) and MCs in rat fibrotic liver, and SCF production by HSCs during culture in vitro. Rats were studied 4, 7, 14 and 21 days after bile duct ligation (BDL). Fibrogenesis was assessed by a measurement of collagen stained with sirius red F3B. Activated HSCs and MCs were identified by ${\alpha}$-smooth muscle actin (${\alpha}-SMA$) immunohistochemical and alcian blue staining and measured by a computerized image analysis system. SCF production was determined in rat HSC cultures using Western blotting. Mild fibrotic changes were noted in BDL rat livers as early as 4 days after induction of cholestasis. Significant expansion and organization of fibrous tissue has occurred in day 14 BDL rats which progressed to bridging fibrosis by day 21. In BDL rats, both a large number of activated HSCs and MCs were detected in portal tracts and fibrous septa. Both area of activated HSCs infiltration and density of MCs were significantly higher in all BDL group compared with Shams. In BDL rats, both areas of activated HSCs infiltration and density of MCs were no significant difference between day 4 and 7 and were significantly higher in day 14. However, the areas of activated HSCs infiltration were significantly lesser in day 21 and the densities of MCs were significantly higher in day 21 compared with day14 BDL. In BDL rats, both areas of activated HSCs infiltration and density of MCs were highly correlated with areas of fibrosis. Western blotting showed that SCF protein was consistently produced in activated HSCs by culture on plastic and freshly isolated HSCs expressed relatively little 30kD SCF compared to late primary culture activated HSCs (day 14) and passaged HSCs. These results suggest that HSCs activated in vitro produce SCF, and may play an important role in recruiting mast cells to the liver during injury and fibrosis.

• Molecules and Cells
• /
• 제38권11호
• /
• pp.966-974
• /
• 2015

Despite the presence of toll like receptor (TLR) expression in conventional $TCR{\alpha}{\beta}$ T cells, the direct role of TLR signaling via myeloid differentiation factor 88 (MyD88) within T lymphocytes on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) effect after allogeneic stem cell transplantation (allo-SCT) remains unknown. In the allo-SCT model of C57BL/6 ($H-2^b$) ${\rightarrow}$ B6D2F1 ($H-2^{b/d}$), recipients received transplants of wild type (WT) T-cell-depleted (TCD) bone marrow (BM) and splenic T cells from either WT or MyD88 deficient (MyD88KO) donors. Host-type ($H-2^d$) P815 mastocytoma or L1210 leukemia cells were injected either subcutaneously or intravenously to generate a GVHD/GVL model. Allogeneic recipients of MyD88KO T cells demonstrated a greater tumor growth without attenuation of GVHD severity. Moreover, GVHD-induced GVL effect, caused by increasing the conditioning intensity was also not observed in the recipients of MyD88KO T cells. In vitro, the absence of MyD88 in T cells resulted in defective cytolytic activity to tumor targets with reduced ability to produce IFN-${\gamma}$ or granzyme B, which are known to critical for the GVL effect. However, donor T cell expansion with effector and memory T-cell differentiation were more enhanced in GVHD hosts of MyD88KO T cells. Recipients of MyD88KO T cells experienced greater expansion of Foxp3- and IL4-expressing T cells with reduced INF-${\gamma}$ producing T cells in the spleen and tumor-draining lymph nodes early after transplantation. Taken together, these results highlight a differential role for MyD88 deficiency on donor T-cells, with decreased GVL effect without attenuation of the GVHD severity after experimental allo-SCT.

• 폴리머
• /
• 제38권3호
• /
• pp.351-357
• /
• 2014

위장관 종양 조직이 스텐트 내로 성장하는 것을 방지하는 피막형 스텐트가 개발되어 널리 사용되고 있으나 위산에 의한 막의 분해로 인해 스텐트 폐쇄나 파손이 있다. 이에 본 연구에서는 위산 환경하에서 막의 성분과 재질 농도에 따른 피막형 스텐트의 물성 변화와 안정성을 살펴보고자 하였다. 스텐트 막의 재질은 실리콘과 폴리우레탄을 사용하였고, 각각의 농도를 15%, 18%, 20%로 하여 제작된 스텐트를 pH 1.2 산성 용액에서 18주 동안 3주 간격으로 변화를 관찰하였다. 피막을 분석한 결과 동일 농도에서 비교하였을 때 실리콘이 폴리우레탄보다 두껍고 균일하게 코팅되었다. 인공 위액에 의한 폴리우레탄 피막의 분해가 실리콘 피막에 비해 심하였다. 반경 방향 팽창력의 크기는 실리콘 피막이 폴리우레탄 피막에 비해 상대적으로 컸다. 반경 방향 팽창력과 변형 회복력 모두 인공 위액에서의 침잠 기간이 경과함에 따라 점차 감소하였고, 폴리우레탄 피막 스텐트에서 감소율이 더 컸다. 결론적으로 실리콘 피막이 폴리우레탄에 비해 위산에 대해 안정성이 높음을 알 수 있었다.

• 생약학회지
• /
• 제37권2호통권145호
• /
• pp.103-109
• /
• 2006

Advanced glycation end products (AGEs) formation plays an important role in the progression of diabetic complications. To develop effective herbal formulations with suppression of diabetic nephropathy, a common complication in diabetic patients, we evaluated inhibitory activities of KIOM-79, a new herbal prescription, on the formation of AGEs using in vitro and in vivo model systems. Effects of KIOM-79 on the expression of AGEs, RAGEs (receptor for Advanced glycation end products), type IV collagen and renal $TGF-{\beta}1$ mRNA was also examined in streptozotocon (STZ)-induced diabetic rats. STZ-induced diabetic rats were treated orally with KIOM-79 (250 and $500\;kg^{-1}$ once a day for 13 weeks). In vitro system KIOM-79 suppressed the formation of AGEs $(18.12\;{\mu}g/ml)$. In STZ-induced diabetic rats showing accumulation of AGE and RAGE, pathological examination revealed that KIOM-79 prevented AGE and RAGE deposition in the kidney. In STZ induced diabetic rats, the expansion of mesangial matrix and the glomerular tufts seemed to be larger than those in normal rats. Howεver, after administration with KIOM-79, mesangial metrix and glomerular volume were decreased, and overexpression of type IV collagen was also decreased. Overexpression of renal $TGF-{\beta}1$ mRNA was inhibited significantly. These results suggest that the KIOM-79 might be an effective herbal prescription to prevent or alleviate the progression of diabetic nephropathy.

• 한국수정란이식학회지
• /
• 제32권4호
• /
• pp.297-304
• /
• 2017

This study was designed to determine the effect of monosodium glutamate (MSG) on in vitro maturation (IVM) of oocytes and early development of parthenogenesis (PA) embryos in pigs. Each IVM and IVC medium was supplemented with various concentrations (0, 0.1, 0.5 and 5 mM) of MSG and non-essential amino acids (NEAA) depending on the experimental design. Immature pig oocytes were matured for 44 h and then oocytes reached metaphase II (MII) stage were electrically activated to induce parthenogenesis (PA). When immature oocytes were treated with MSG in the absence of NEAA during IVM, nuclear maturation (83.1-87.1%), intra-oocyte glutathione content, cumulus expansion, and cleavage (91.4-93.4%) of PA embryos were not influenced by MSG treatment at all concentrations. However, blastocyst formation of PA embryos was significantly increased by 5.0 mM MSG ($45.3{\pm}6.2%$) compared to control ($25.6{\pm}3.4%$). MSG treatment during IVM in the presence of NEAA did not show significant effect on nuclear maturation of oocytes and blastocyst formation after PA while 0.5 mM MSG ($89.3{\pm}1.9%$) decreased (P < 0.05) cleavage of PA embryos compared to 0.1 mM MSG ($94.6{\pm}1.1%$). When PA embryos were treated for 7 days with MSG during IVC, 5.0 mM MSG significantly decreased blastocyst formation ($27.8{\pm}4.9%$) compared to no treatment ($41.4{\pm}1.9%$) while no decrease in blastocyst formation was observed in 0.1 and 0.5 mM ($37.4{\pm}3.4%$ and $34.4{\pm}2.6%$, respectively). Our results demonstrated that 5 mM MSG in a NEAA-free chemically defined maturation medium showed positive effect on PA embryonic development while 5 mM MSG treatment during IVC was deleterious to PA embryonic development in pigs.

• IMMUNE NETWORK
• /
• 제1권1호
• /
• pp.61-69
• /
• 2001

Background: To determine the molecular structure of type II collagen-specific T-cell receptors associated with rheumatoid arthritis (RA). Methods: We generated CII-specific T-cell lines of 8 RA patients by prolonged in vitro culture with bovine CII (bCII) and the immunogenic peptide (256-270) of human CII. The proliferation response towards CII stimulation was measured from the uptake of 3H-thymidine. Changes in the secretion of Th 1 and Th2 cytokines in the culture supernatent were measured by ELISA. The TCR clonotypes of these T-cells were examined by RT-PCR/SSCP analyses of all 22 $V_{\beta}$ chains. Results: T-cells from patients' tissue exhibited strong proliferation index upon CII stimulation, which was maintained up to 6 months in the culture. The secretion of INF-$\gamma$from these T-cells increased along with the duration of culture time, while the amount of IL-4 production did not show significant changes. The SSCP band patterns of patients' T-cells appear as discrete bands unlike the smeary streak produced from normal samples. Some SSCP bands, each representing selected expansion of a TCR containing certain subtype of $V_{\beta}$ peptides, appeared to be identical in more than one patients. Among these, the expansion of SSCP band representing the $V_{\beta}$ 14 CDR3 region persisted after switching the antigen to the immunogenic human peptide (256-270). Conclusion: CII-reactive T-cells expressing distinct CDR3 motifs are selectively expanded in the peripheral blood and synovial fluid of RA patients, and their persistent proliferation upon CII stimulation, as well as the production Th 1-type cytokines, may play pivotal roles in RA pathogenesis.

• Journal of Periodontal and Implant Science
• /
• 제47권5호
• /
• pp.292-311
• /
• 2017

Purpose: Beyond the limited scope of non-specific polyclonal regulatory T cell (Treg)-based immunotherapy, which depends largely on serendipity, the present study explored a target Treg subset appropriate for the delivery of a novel epitope spreader Pep19 antigen as part of a sophisticated form of immunotherapy with defined antigen specificity that induces immune tolerance. Methods: Human polyclonal $CD4^+CD25^+CD127^{lo-}$ Tregs (127-Tregs) and $na\ddot{i}ve$ $CD4^+CD25^+CD45RA^+$ Tregs (45RA-Tregs) were isolated and were stimulated with target peptide 19 (Pep19)-pulsed dendritic cells in a tolerogenic milieu followed by ex vivo expansion. Low-dose interleukin-2 (IL-2) and rapamycin were added to selectively exclude the outgrowth of contaminating effector T cells (Teffs). The following parameters were investigated in the expanded antigen-specific Tregs: the distinct expression of the immunosuppressive Treg marker Foxp3, epigenetic stability (demethylation in the Treg-specific demethylated region), the suppression of Teffs, expression of the homing receptors CD62L/CCR7, and CD95L-mediated apoptosis. The expanded Tregs were adoptively transferred into an $NOD/scid/IL-2R{\gamma}^{-/-}$ mouse model of collagen-induced arthritis. Results: Epitope-spreader Pep19 targeting by 45RA-Tregs led to an outstanding in vitro suppressive T cell fate characterized by robust ex vivo expansion, the salient expression of Foxp3, high epigenetic stability, enhanced T cell suppression, modest expression of CD62L/CCR7, and higher resistance to CD95L-mediated apoptosis. After adoptive transfer, the distinct fate of these T cells demonstrated a potent in vivo immunotherapeutic capability, as indicated by the complete elimination of footpad swelling, prolonged survival, minimal histopathological changes, and preferential localization of $CD4^+CD25^+$ Tregs at the articular joints in a mechanistic and orchestrated way. Conclusions: We propose human $na\ddot{i}ve$ $CD4^+CD25^+CD45RA^+$ Tregs and the epitope spreader Pep19 as cellular and molecular targets for a novel antigen-specific Treg-based vaccination against collagen-induced arthritis.

• 미생물학회지
• /
• 제54권4호
• /
• pp.420-427
• /
• 2018

효모균 타이로실-tRNA 합성효소(Sc YRS)와 엠버 멈춤코돈을 인식하는 대장균 시작tRNA 변이체(fMam $tRNA_{CUA}$)쌍은 대장균에서 단백질 생합성시 원하는 특정 위치에 비천연아미노산을 도입하는데 활용된다. Sc YRS/fMam $tRNA_{CUA}$쌍의 엠버써프레션 활성을 높이기 위해 fMam $tRNA_{CUA}$의 첫번째 안티코돈 염기를 인식하는 Sc YRS의 320번, 321번 아미노산 잔기를 암호화하는 염기서열을 무작위로 돌연변이시킨 라이브러리를 제작하였다. 엠버써프레션에 의한 클로람페니콜 저항성을 이용해 라이브러리를 탐색하여 활성이 향상된 2개의 돌연변이주를 선별하였다. 이들의 클로람페니콜 저항성 성장의 $IC_{50}$값은 야생형 YRS보다 1.7~2.3배 높았으며, in vivo 엠버써프레션 활성을 비교한 결과 3~6.5배의 활성 증가가 나타났다. 높은 활성을 보인 mYRS-3 (P320A/D321A) 단백질의 fMam $tRNA_{CUA}$에 대한 in vitro aminoacylation kinetics 분석은 야생형보다 약 7배 높은 효소활성을 보였으며, 이는 주로 기질인 fMam $tRNA_{CUA}$에 대한 결합 친화도가 증가하여 나타났다. 이런 접근법을 이용하여 다양한 종류의 비천연 아미노산 도입에 활용되는 aminoacyl-tRNA 합성효소의 엠버써프레션 활성을 높임으로써 엠버 멈춤코돈을 이용한 비천연 아미노산 도입 효율성을 높일 수 있을 것이다.